Eastgate Biotech Corp. (ETBI)
OTCMKTS
· Delayed Price · Currency is USD
0.0045
+0.0045 (449,900.00%)
At close: Apr 10, 2025
Eastgate Biotech Revenue
Eastgate Biotech had revenue of $23.14K in the quarter ending September 30, 2017. This brings the company's revenue in the last twelve months to $137.64K, up 45,325.08% year-over-year.
Revenue (ttm)
137.64K
Revenue Growth
+45,325.08%
P/S Ratio
34.59
Revenue / Employee
45.88K
Employees
3
Market Cap
4.76M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
SS Innovations International | 20.65M |
Veradigm | 588.02M |
Northwest Biotherapeutics | 1.38M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 200.90M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |